Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses.

Area of Science:

• Immunology
• Cellular Biology
• Autoimmune Diseases

Background:

• CD4(+) T cells drive inflammation and tissue damage in immune dysregulation.
• Memory T cells, established early in disease, are traditionally resistant to tolerance induction.
• Effective immunotherapies must target and terminate established memory T-cell responses.

Purpose of the Study:

• To investigate if transgenic antigen expression in dendritic cells (DCs) can terminate CD4(+) memory T-cell responses.
• To explore a novel immunotherapy approach for established T-cell-mediated diseases.

Main Methods:

• Generating CD4(+) memory T cells in vitro.
• Transferring these cells into non-transgenic and transgenic mice expressing cognate antigen in steady-state DCs.
• Assessing proliferation, deletion, and recall responses of transferred T cells.

Main Results:

• Transfer of CD4(+) memory T cells into non-transgenic recipients established stable, recallable memory responses.
• Transfer into mice with DC-targeted antigen expression led to limited T-cell proliferation followed by substantial deletion.
• Immune recall responses were effectively silenced in transgenic recipients.

Conclusions:

• Transgenic antigen expression in steady-state DCs provides a viable strategy to terminate CD4(+) memory T-cell responses.
• This approach offers a promising avenue for immunotherapy in ongoing T-cell-mediated autoimmune and inflammatory diseases.
• Findings challenge the notion of memory T-cell resistance to tolerance induction.